Bill 119 s 331, also known as the Fentanyl Scheduling Act, is a proposed piece of legislation that aims to make changes to the Controlled Substances Act in regards to the scheduling of fentanyl-related substances. The main purpose of this bill is to address the growing issue of fentanyl-related overdoses and deaths in the United States.
The bill seeks to reclassify certain fentanyl-related substances as Schedule I controlled substances, which are considered to have a high potential for abuse and no accepted medical use. By doing so, the bill aims to make it more difficult for these substances to be manufactured, distributed, and abused.
In addition to the scheduling changes, the bill also includes provisions for increasing penalties for the trafficking and distribution of fentanyl-related substances. This is intended to deter individuals and organizations from engaging in the illegal production and distribution of these dangerous drugs.
Overall, the Fentanyl Scheduling Act is a response to the growing public health crisis surrounding fentanyl-related overdoses and deaths. By reclassifying these substances and increasing penalties for their trafficking, the bill aims to combat the spread of fentanyl abuse and prevent further harm to individuals and communities across the country.